Feasibility of imaging pentose cycle glucose metabolism in gliomas with PET: Studies in rat brain tumor models

Journal of Nuclear Medicine

Volumn 38, Issue 4, 1997, Pages 617-624

  Spence, Alexander M ^a   Graham, M M ^a   Muzi, M ^a   Freeman, S D ^a   Link, J M ^a   Grierson, J R ^a   O'Sullivan, F ^a   Stein, D ^a   Abbott, G L ^a   Krohn, K A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

brain neoplasm; glucose metabolism; pentose cycle; PET; rat glioma

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; DIAGNOSTIC ACCURACY; GLIOMA; GLUCOSE METABOLISM; IMAGE ANALYSIS; MATHEMATICAL MODEL; NONHUMAN; PENTOSE PHOSPHATE CYCLE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RAT; SYSTEM ANALYSIS; TUMOR MODEL;

EID: 0030893257     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Colcman RE. Hoffman JM. Hanson MW, Sostman HD. Schuld SCJ. Clinical application of PKT for the evaluation of brain tumors../ Nucl Med 1991;32:616-622.
2. Di Chiro G. Positron emission tomography using F]fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radio! 1987;22:360-371.
3. Glantz MJ, Hoffman JM. Coleman RE, et al. Identification of early recurrence of primary central nervous system tumors hy ['Flfluorodeoxyglueosc positron emission tomography. Ann Neural 1991:29:347-355.
4. Herhob. K. Pietrzyk U. Voges J. et al. Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotaetic PET study. J Neurosurg 1993:79:853 858.
5. Tyler JE. Diksic M, Villemure JG. et al. Metabolic and hemodynamic evaluation of gliomas using positron emission tomography../ Nucl Med 1987:28:1123-1133.
6. Sokoloff L, Reivich M. Kennedy C, el al. The ['4C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure and normal values in the conscious and anesthetized albino rat../ Neurochem 1977:28:897-916.
7. Weber G. Enzymology of cancer cells (first of two pans). N Engl J Med 1977:296: 486-492.
8. Weber G. Enzymology of cancer cells (second of two parts). ,V Engl J Med 1977:296:541-551.
9. Coleman MT. Alien N. The hexose monophosphate pathway in ethylnitrosourea induced tumors of the nervous system. J Nettrochent 1978:30:83-90.
10. Hothersall JS. Baquer NZ, McLean P. Pathways of carbohydrate metabolism in peripheral nervous tissue. I. The contribution of alternative routes of glucose utilization in peripheral nerve and brain. Enzyme 1982:27:259-267.
11. Domanska-Janik K.. Hexose monophosphate pathway activity in normal and hypoxic rat brain. Resuscitation 1988:16:79-90.
12. Zubairu S, Hothersall JS. El-Hassan A. McLean P. Greenbaum AL. Alternative pathways of glucose utilization in brain: changes in the pattern of glucose utilization and of the response of the pentose phosphate pathway to 5-hydroxytryptamine during aging. J Neurochem 1983:41:76- 83.
13. Gaitonde MK. F.vison E, Evans GM. The rate of utilization of glucose via hexosemonophosphate shunt in brain. J Neurochem 1983:41:1253-1260.
14. Loreck DJ. Galarraga J, Van der Feen J. Phang JM. Smith BH, Cummins CJ. Regulation of the pentose phosphate pathway in human astrocytes and gliomas. Metab Bruin UK 1987:2:31 -46.
15. Alien N. Respiration and oxidative metabolism of brain tumors. In: Kirsch WM. Paoletti FXi, Paoletti P. eds. The experimental biology of brain tumors. Springfield. IL: Charles C Thomas: 1972:243 274.
16. Lowry OH, Berger SJ, Carter JG. et al. Diversity of metabolic patterns in human brain tumors: enzymes of energy metabolism and related metabolites and cofactors. J Neurochem 1983:41:994 1010.
17. Marzatico F. Curli D. Dagani F, et al. Enzymes related to energy metabolism in human gliomas../ Neurosurg Sei 1986:30:129-132.
18. Timperley WR. Glycolysis in neuroeclodermal tumors. In: Thomas DGT. Graham DI. eds. Brain tumors, scientific basis, clinical investigation and current therapy. London: Butterworths: 1980:145 167.
19. Coleman MT. Allen N. Activities of enzymes of the hexose monophosphate pathway in nervous system tumors induced by ethylnitrosourea. Ada Neuropathol (Berlin) 1978:41:223-227.
20. Kingsley-Hickman PB. Ross BU. Krick T. Hexose monophosphate shunt measurement in cultured cells with [l-nC]glucose: correction for endogenous carbon sources using [6-C] glucose. Anal Biochem 1990:185:235 237.
21. Ross BD. Higgins RJ, Boggan JE, Willis JA. Knittel B. Linger SW. Carbohydrate metabolism of the rat C6 glioma. An in vivo RC and in vitro 111 magnetic resonance spectroscopy study. NMR Biomed 1988:1:20-26.
22. Hotta SS. Seventko JMJ. The hexosemonophosphate shunt and glutathione reduction in guinea pig brain tissue: changes caused by chlorpromazine, amytal and malonate. Arch Biochem Biophys 1968:123:104-108.
23. Hawkins RA. Mans AM. Davis DW. Vina JR. Ilibbard LS. Cerebral glucose use measured with [HC]glucose labeled in the 1. 2 or 6 position. Am J Physiol 1985:248;C170 C176.
24. Baquer NZ, Hothersall JS. McLean P. Function and regulation of the pentose phosphate pathway in brain. Curr Top Cell Regul 1988;29:265- 289.
25. Benda P. Lightbody J. Sato G, Levine L. Sweet W. Differentiated rat glial cell strain in tissue culture. Science 1968:161:370 371.
26. Spence AM, Coates PW. Scanning electron microscopy of cloned astrocytic lines derived from ethylnitrosourea-induced rat gliomas. Yin-hows Arch B Cell Pathol 1978:28:77-85.
27. MacGregor RR, Fowler JS, Wolf AP, Shiue CY, Lade RE, Wan CN. A synthesis of 2-deoxy-D-[l-C]glucose for regional metabolic studies: concise communication. J Nucl Med 1981:22:800-803.
28. Spence AM, Graham MM, Muzi M, et al. Deoxyglucose lumped constant estimated in a transplanted rat astrocytic glioma by the hexose utilization index. J Cereb Blood Flow Metab 1990:10:190-198.
29. Link JM, Courter JH, Krohn KA. Remote automated synthesis of 1-[C-1 l]-D-glucose for patient imaging with PET. J Nucl Med 1989:30:928.
30. Shiue C-Y, Wolf AP. The synthesis of l-[C]-D-glucose and related compounds for the measurement of brain glucose metabolism. ./Label Compds Radiopharm 1985:22: 171 182.
31. Dence CS. Powers WJ, Welch MJ. Improved synthesis of l-[C]D-glucose. Appl Radiât Isot 1993:44:971-980.
32. Grierson JR. Biskupiak JE, Link JM, Krohn KA. Radiosynthesis of 6-[C-l 1]-Dglucose. Appl Radial Isot 1993:44:1449-1458.
33. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951:193:265-275.
34. Barker M, Hoshino T, Gurcay O, et al. Development of an animal brain tumor model and its response to therapy with l,3-bis(2-chloroethyl)-l-nitrosourea. Cancer Res 1973;33:976-986.
35. 2 yields from glucose-1- and -6-14C for the evaluation of the pathways of glucose metabolism../ Biol Chem 1963;238:517-:i23.
36. Blomqvist G. Stone-Elander S. Halldin C, et al. Positron emission tomogn phic measurements of eerebral glucose utilization using [l-C]D-glucose. ./ Cereb blood Flo-x Metab 1990:10:467-483.
37. Press WH. Flannery BP. Teukolsky SA. Vetterling WT. Numerical recipes in Pascal. New York: Cambridge University Press: 1989.
38. Thompson ML, Zucchini W. On the statistical analysis of ROC curves. Stai Mud 1989:8:1277-1290.
39. Spence AM. Graham MM, Muzi M, et al. Assessment of glucose metabolism in malignant gliomas: Use of deoxyglucosc or glucose. Second European Workshop on FDG in Oncology. Heidelberg. Germany: 1991:9-11.
40. Spence AM. Muzi M, Graham MM, Freeman SD. Berger MS. Ojemann GA. Analysis of the deoxyglucose lumped constant in human malignant gliomas. Ann .Vt urol 1991:30:271-272.
41. Phelps ME, Huang SC, Huffman EJ, Selin C. Sokoloff L. Kühl DE. Tomographie measurement of local cerebral glucose metabolic rate in humans with (F-18)2-flioro2-deoxy-D-glucose: validation of method. Ann Neural 1979:6:371-388.